Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association Accepted for Coverage in MEDLINE
Inclusion means improved access to the Journal for researchers and practitioners worldwide
Philadelphia, July 24, 2008 – Elsevier and the Alzheimer’s Association announced that Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association has been selected for inclusion in MEDLINE. MEDLINE is the premier bibliographic database of the National Library of Medicine (NLM). Part of the National Institutes of Health (NIH), MEDLINE contains over 16 million journal article citations, with a concentration on biomedicine.
“The entire Editorial Board and I are extremely pleased that Alzheimer’s & Dementia is being added to the MEDLINE journal collection so soon after its launch in 2005,” Alzheimer’s & Dementia Editor Zaven Khachaturian, PhD, commented. “Inclusion in this prominent database signals recognition of the journal’s scientific merit and contribution to the field of Alzheimer’s research. More importantly, MEDLINE indexing will help researchers and other interested parties worldwide to locate articles published in Alzheimer’s & Dementia.”
As the official journal of the Alzheimer’s Association, the peer-reviewed Alzheimer’s & Dementia is distributed bimonthly to members of the Association’s International Society to Advance Alzheimer Research and Treatment (ISTAART), as well as other subscribers and libraries. Alzheimer’s & Dementia addresses challenging issues facing researchers, clinicians and health policymakers on topics from healthy brain aging to all forms of dementia. Unlike other journals in the field, Alzheimer’s & Dementia brings together breakthrough research and new thinking across diverse areas of investigation. This interdisciplinary journal provides the impetus for new scientific initiatives and offers probing, thought-provoking studies, articles and reviews from the leading minds in the field.
“With Alzheimer’s research increasingly garnering international attention and interest, it is critical for clinicians and investigators in this interdisciplinary field to have the most cutting edge, authoritative information available,” said William Thies, PhD, Vice President for Medical & Scientific Relations at the Alzheimer’s Association. “Progress is being made, and we are beginning to reap the benefits of scientific advancements made in the last two decades. But we must move the field forward more quickly for the benefit of the millions now with Alzheimer’s, their caregivers and family members. Alzheimer’s & Dementia can play an important role in doing that.”
As publishing partners, the Alzheimer’s Association and Elsevier are delighted that researchers and practitioners worldwide can now easily find the valuable information offered in Alzheimer’s & Dementia through MEDLINE.
# # #
About the Alzheimer’s Association
Founded in 1980, the Alzheimer’s Association is the leading U.S. voluntary health organization in Alzheimer care, support and research. The mission of the Alzheimer’s Association is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. For information, please visit www.alz.org.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Tel: +1 215 239 3652